openPR Logo
Press release

HIV Self Tests Market Sales and Consumption Status and Prospects Professional Market Research Report

10-16-2020 10:17 AM CET | Health & Medicine

Press release from: Transparency Market Research

HIV Self Tests Market: Introduction

HIV self test is a rapid test as it presents quicker results and is easy to perform. HIV self tests are also called point-of-care tests in HIV diagnosis. These tests can detect HIV antibodies and antigen, while some tests can detect both. HIV self tests can be performed using oral fluid, dried blood spots, etc.
Low cost, ease of usage, quick results, and high specificity and sensitivity are few factors driving the growth of the market
According to the WHO, global HIV self-test procurement volumes exceeded 1 million tests in 2017 and are estimated to increase rapidly to 16.4 million by the end of 2020
View Report :https://www.transparencymarketresearch.com/hiv-self-tests-market.html

Key Drivers of Global HIV Self Tests Market

Rise in prevalence of HIV is projected to increase the demand for HIV self testing kits, which, in turn, is anticipated to boost the growth of the market. According to the WHO, HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. In 2018, 770,000 people died of HIV-related causes globally.
Rise in adoption rate of HIV self-tests is projected to drive the HIV self tests market during the forecast period
Increase in awareness about importance of HIV diagnosis is expected to drive the market during the forecast period. According to the United Nations University (UNU) estimates, the percentage of the world population above 65 years of age is anticipated to increase from 9% in 2010 to 16% by 2050.
Get Brochure of the Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74638

North America to Hold Major Share of Global HIV Self Tests Market

North America is a leading market for HIV self tests. Growth of the market in the U.S. can be attributed to increase in the seroprevalence of the disease in the country. The efforts to increase awareness about the adverse effects in certain cases if left undiagnosed and untreated contributes to the increase in demand for diagnosis. Growth of the market in the region can be attributed to the increase in adoption of HIV self tests kits by young individuals.
Governments of the European countries have favorable reimbursement policies. This is anticipated to propel the market in Europe during the forecast period. Health care reimbursement is reforming significantly, which is driving people to undertake HIV self testing.
HIV self tests market in Asia Pacific is projected to grow at a rapid pace in the near future. India and China are anticipated to be lucrative markets for HIV self testing kits during the forecast period, owing to high prevalence of HIV. Increase in awareness and implementation of government programs for HIV testing in pregnant woman is driving the growth of the segment.
Inclination toward the use of self testing kits in medical practice and overall improvement in health care infrastructure are major factors boosting the HIV self tests market in Asia Pacific
Request For Covid19 Impact Analysis –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74638

Key Players Operating in Global Market

Major players operating in the global HIV self tests market are:

Atomo Diagnostics
BioSURE United Kingdom, Ltd.
Biosynex Group
bioLytical Laboratories
OraSure Technologies, Inc.
Chembio Diagnostic Systems, Inc.
Orangelife Comércio e Indústria LTDA
Bedford Biotech Nigeria
Sedia Biosciences Corporation
Global HIV Self Tests Market: Research Scope

Global HIV Self Tests Market, by Specimen Type

Blood
Oral Fluid
Urine
Buy Now Report :https://www.transparencymarketresearch.com/checkout.php?rep_id=74638

Contact

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Self Tests Market Sales and Consumption Status and Prospects Professional Market Research Report here

News-ID: 2161766 • Views:

More Releases from Transparency Market Research

Global Galvanized Steel Coil Market for Building Materials Poised to Reach USD 57.2 Bn | Transparency Market Research
Global Galvanized Steel Coil Market for Building Materials Poised to Reach USD 5 …
The global Galvanized Steel Coil Market for Building Materials is entering a high-growth period driven by rapid urbanization, rising investment in infrastructure, sustainability-focused construction practices, and advanced corrosion-resistant technologies. According to the latest industry outlook, the market-valued at USD 32.6 Bn in 2024-is projected to expand at a CAGR of 5.3% from 2025 to 2035, reaching USD 57.2 Bn by 2035. This press release presents a comprehensive analysis of the market,
Global Silage Film Market Set to Reach USD 5.5 Billion by 2034, Driven by Sustainable Agriculture and Rising Livestock Production
Global Silage Film Market Set to Reach USD 5.5 Billion by 2034, Driven by Sustai …
The global agricultural landscape is undergoing a transformative shift as farmers worldwide adopt modern techniques to enhance crop preservation, livestock feed quality, and operational efficiency. One of the key enablers of this transition is the growing use of silage films-high-performance protective coverings used to store and preserve forage. According to the latest industry assessment, the global silage film market, valued at US$ 2.9 Bn in 2023, is projected to expand
Global Canine Atopic Dermatitis Market Set to Surpass USD 431.0 Million by 2035 Amid Rising Pet Ownership and Advancements in Veterinary Dermatology
Global Canine Atopic Dermatitis Market Set to Surpass USD 431.0 Million by 2035 …
The global Canine Atopic Dermatitis Market is poised for strong long-term expansion, projected to grow at a CAGR of 5.8% from 2025 to 2035, increasing from US$ 231.4 Mn in 2024 to more than US$ 431.0 Mn by 2035. Rising cases of allergic skin disorders in dogs, soaring pet adoption rates, and heightened awareness of pet health are collectively shaping the future trajectory of this dynamic industry. Introduction: Canine atopic dermatitis
Global Bio-Based Polyethylene Furanoate (PEF) Market Set for Strong Expansion, Projected to Reach USD 31.4 Million by 2035 | TMR
Global Bio-Based Polyethylene Furanoate (PEF) Market Set for Strong Expansion, P …
The global Bio-Based Polyethylene Furanoate (PEF) Market is gaining remarkable momentum as industries worldwide accelerate the shift toward renewable, recyclable, and low-carbon polymer solutions. According to the latest market assessment, the bio-based PEF industry, valued at US$ 13.4 Mn in 2024, is projected to grow at a CAGR of 8.1% between 2025 and 2035, reaching an estimated US$ 31.4 Mn by 2035. Increasing sustainability requirements, consumer demand for eco-friendly packaging,

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways